Assessment

• Observe for signs of hypokalemia (muscle weakness, malaise, fatigue, ECG changes, vomiting)

» Assess for allergy to sulfonamides

• Assess for eye discomfort or decrease in visual acuity

• Monitor neurologic status in patients receiving acetazolamide for seizures. Initiate seizure precautions

• Monitor for decrease in severity of symptoms (headache, nausea, vomiting, fatigue, dizziness, drowsiness, shortness of breath). Notify health care professional immediately if neurologic symptoms worsen or if patient becomes more dyspneic and rales or crackles develop

• Serum electrolytes, complete blood counts, and platelet counts should be evaluated initially and periodically throughout prolonged therapy. May cause potassium, bicarbonate, WBCs, and RBCs. May cause serum chloride

» May cause in serum and urine glucose; monitor serum and urine glucose carefully in diabetic patients

» May cause false-positive results for urine protein and 17-hydroxysteroid tests

» May cause blood ammonia, bilirubin, uric acid, urine urobilinogen, and calcium. May urine citrate

acetaZOLAMIDE is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.